André Dallmann

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Network Analysis

Top Venues

Journal of clinical pharmacology

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Xavier J H Pepin, Sumit Arora, Luiza Borges, Mario Cano-Vega, Tessa Carducci, Parnali Chatterjee, Grace Chen, Rodrigo Cristofoletti, André Dallmann, Poonam Delvadia, Jennifer Dressman, Nikoletta Fotaki, Elizabeth Gray, Tycho Heimbach, Øyvind Holte, Shinichi Kijima, Evangelos Kotzagiorgis, Hans Lennernäs, Anders Lindahl, Raimar Loebenberg, Claire Mackie, Maria Malamatari, Mark McAllister, Amitava Mitra, Rebecca Moody, Deanna M Mudie, Flora Musuamba Tshinanu, James E Polli, Bhagwant Rege, Xiaojun Ren, Gregory Rullo, Megerle Scherholz, Ivy Song, Cordula Stillhart, Sandra Suarez-Sharp, Christer Tannergren, Eleftheria Tsakalozou, Shereeni Veerasingham, Christian Wagner, Paul Seo
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report. Molecular pharmaceutics (2024)
Xavier J H Pepin, Sumit Arora, Luiza Borges, Mario Cano-Vega, Tessa Carducci, Parnali Chatterjee, Grace Chen, Rodrigo Cristofoletti, André Dallmann, Poonam Delvadia, Jennifer Dressman, Nikoletta Fotaki, Elizabeth Gray, Tycho Heimbach, Øyvind Holte, Shinichi Kijima, Evangelos Kotzagiorgis, Hans Lennernäs, Anders Lindahl, Raimar Loebenberg, Claire Mackie, Maria Malamatari, Mark McAllister, Amitava Mitra, Rebecca Moody, Deanna M Mudie, Flora Musuamba Tshinanu, James E Polli, Bhagwant Rege, Xiaojun Ren, Gregory Rullo, Megerle Scherholz, Ivy Song, Cordula Stillhart, Sandra Suarez-Sharp, Christer Tannergren, Eleftheria Tsakalozou, Shereeni Veerasingham, Christian Wagner, Paul Seo
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report. Molecular pharmaceutics 21 (8) (2024)
Xiaomei I Liu, Dionna J Green, John van den Anker, Joaquin Calderon, Homa Ahmadzia, Gilbert J Burckart, André Dallmann
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. Journal of clinical pharmacology (2024)
Karel Allegaert, Sara K Quinney, André Dallmann
Physiologically Based Pharmacokinetic Modeling in Pregnancy, during Lactation and in Neonates: Achievements, Challenges and Future Directions. Pharmaceutics 16 (4) (2024)
Karel Allegaert, Sara K Quinney, André Dallmann
Physiologically Based Pharmacokinetic Modeling in Pregnancy, during Lactation and in Neonates: Achievements, Challenges and Future Directions. Pharmaceutics 16 (4) (2024)
André Dallmann, Peter L Bonate, Janelle M Burnham, Blessy A George, Lynne Yao, Jane Knöchel
Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicine. CPT: pharmacometrics & systems pharmacology (2024)
André Dallmann, Donato Teutonico, Stephan Schaller, Rolf Burghaus, Sebastian Frechen
In-Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community. Journal of clinical pharmacology (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Karel Allegaert, Sara K Quinney, André Dallmann
Physiologically Based Pharmacokinetic Modeling in Pregnancy, during Lactation and in Neonates: Achievements, Challenges and Future Directions. Pharmaceutics 16 (4) (2024)
Xiaomei I Liu, Dionna J Green, John van den Anker, Joaquin Calderon, Homa Ahmadzia, Gilbert J Burckart, André Dallmann
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. Journal of clinical pharmacology (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Xavier J H Pepin, Sumit Arora, Luiza Borges, Mario Cano-Vega, Tessa Carducci, Parnali Chatterjee, Grace Chen, Rodrigo Cristofoletti, André Dallmann, Poonam Delvadia, Jennifer Dressman, Nikoletta Fotaki, Elizabeth Gray, Tycho Heimbach, Øyvind Holte, Shinichi Kijima, Evangelos Kotzagiorgis, Hans Lennernäs, Anders Lindahl, Raimar Loebenberg, Claire Mackie, Maria Malamatari, Mark McAllister, Amitava Mitra, Rebecca Moody, Deanna M Mudie, Flora Musuamba Tshinanu, James E Polli, Bhagwant Rege, Xiaojun Ren, Gregory Rullo, Megerle Scherholz, Ivy Song, Cordula Stillhart, Sandra Suarez-Sharp, Christer Tannergren, Eleftheria Tsakalozou, Shereeni Veerasingham, Christian Wagner, Paul Seo
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report. Molecular pharmaceutics 21 (8) (2024)
André Dallmann, Donato Teutonico, Stephan Schaller, Rolf Burghaus, Sebastian Frechen
In-Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community. Journal of clinical pharmacology 64 (9) (2024)
Xavier J H Pepin, Sumit Arora, Luiza Borges, Mario Cano-Vega, Tessa Carducci, Parnali Chatterjee, Grace Chen, Rodrigo Cristofoletti, André Dallmann, Poonam Delvadia, Jennifer Dressman, Nikoletta Fotaki, Elizabeth Gray, Tycho Heimbach, Øyvind Holte, Shinichi Kijima, Evangelos Kotzagiorgis, Hans Lennernäs, Anders Lindahl, Raimar Loebenberg, Claire Mackie, Maria Malamatari, Mark McAllister, Amitava Mitra, Rebecca Moody, Deanna M Mudie, Flora Musuamba Tshinanu, James E Polli, Bhagwant Rege, Xiaojun Ren, Gregory Rullo, Megerle Scherholz, Ivy Song, Cordula Stillhart, Sandra Suarez-Sharp, Christer Tannergren, Eleftheria Tsakalozou, Shereeni Veerasingham, Christian Wagner, Paul Seo
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report. Molecular pharmaceutics 21 (8) (2024)
Sebastian Frechen, Ibrahim Ince, André Dallmann, Michael Gerisch, Natalia A Jungmann, Corina Becker, Maximilian Lobmeyer, Maria E Trujillo, Shiyao Xu, Rolf Burghaus, Michaela Meyer
Applied Physiologically Based Pharmacokinetic Modeling to assess UGT-mediated Drug-Drug Interactions for Vericiguat. CPT: pharmacometrics & systems pharmacology (2023)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
André Dallmann, John van den Anker, Homa K Ahmadzia, Natella Rakhmanina
Mechanistic Modeling of the Drug-Drug Interaction Between Efavirenz and Dolutegravir: Is This Interaction Clinically Relevant When Switching From Efavirenz to Dolutegravir During Pregnancy? Journal of clinical pharmacology (2023)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
Christian Maass, Stephan Schaller, André Dallmann, Kathrin Bothe, Dennis Müller
Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study. Toxicological sciences : an official journal of the Society of Toxicology 192 (1) (2023)
Christian Maass, Stephan Schaller, André Dallmann, Kathrin Bothe, Dennis Müller
Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study. Toxicological sciences : an official journal of the Society of Toxicology 192 (1) (2023)
Gilbert J Burckart, John van den Anker, André Dallmann
Fetal Clinical Pharmacology: A New Frontier of Drug Safety and Therapeutics. Journal of clinical pharmacology (2022)
Xiaomei Liu, André Dallmann, Kristina Brooks, Brookie M Best, Diana F Clarke, Mark Mirochnick, John N van den Anker, Edmund V Capparelli, Jeremiah D Momper
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT: pharmacometrics & systems pharmacology (2022)
Sofie A M Brookhuis, Karel Allegaert, Lidwien M Hanff, Marjolijn N Lub-de Hooge, André Dallmann, Paola Mian
Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population. Pharmaceutics 13 (8) (2021)
Sebastian Frechen, Juri Solodenko, Thomas Wendl, André Dallmann, Ibrahim Ince, Thorsten Lehr, Joerg Lippert, Rolf Burghaus
A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions. CPT: pharmacometrics & systems pharmacology 10 (6) (2021)
André Dallmann, Xiaomei I Liu, Gilbert J Burckart, John van den Anker
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer. Journal of clinical pharmacology (2020)
André Dallmann, Anneke Himstedt, Juri Solodenko, Ibrahim Ince, Georg Hempel, Thomas Eissing
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery. Journal of pharmacokinetics and pharmacodynamics 47 (4) (2020)
André Dallmann, Ibrahim Ince, Katrin Coboeken, Thomas Eissing, Georg Hempel
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Clinical pharmacokinetics 57 (6) (2019)
André Dallmann, John van den Anker, Marc Pfister, Gilbert Koch
Characterization of Maternal and Neonatal Pharmacokinetic Behavior of Ceftazidime. Journal of clinical pharmacology 59 (1) (2018)